Subthreshold Nanosecond Laser, from Trials to Real-Life Clinical Practice: A Cohort Study

References

• Birch DG, Liang FQ. Age-related macular degeneration: a target for nanotechnology derived medicines. Int J Nanomedicine. 2007;2(1):65. doi:10.2147/nano.2007.2.1.65
   PubMed Web of Science ®Google Scholar
• Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet. 2009;374(9696):1196–1208. doi:10.1016/S0140-6736(09)61460-4
   PubMed Web of Science ®Google Scholar
• Chirco KR, Sohn EH, Stone EM, Tucker BA, Mullins RF. Structural and molecular changes in the aging choroid: implications for age-related macular degeneration. Eye. 2017;31(1):10–25. doi:10.1038/eye.2016.216
   PubMed Web of Science ®Google Scholar
• Ferris FL, Davis MD, Clemons TE, et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol. 2005;123(11):1570–1574.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Daniel E, Maguire MG, et al.; Comparison of Age-Related Macular Degeneration Treatments Trials Research Group. Pseudodrusen and incidence of late age-related macular degeneration in fellow eyes in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2016;123(7):1530–1540. doi:10.1016/j.ophtha.2016.02.043
   Web of Science ®Google Scholar
• Gil JQ, Marques JP, Hogg R, et al. Clinical features and long-term progression of reticular pseudodrusen in age-related macular degeneration: findings from a multicenter cohort. Eye. 2017;31(3):364–371. doi:10.1038/eye.2016.207
   PubMed Web of Science ®Google Scholar
• Wood JP, Plunkett M, Casson RJ, Chidlow G. Retinal damage profiles and neuronal effects of laser treatment: comparison of a conventional photocoagulator and a novel 3-nanosecond pulse laser. Invest Ophthalmol Vis Sci. 2013;54(3):2305–2318. doi:10.1167/iovs.12-11203
   Web of Science ®Google Scholar
• Mojana F, Brar M, Cheng L, Bartsch DU, Freeman WR. Long-term SD-OCT/SLO imaging of neuroretina and retinal pigment epithelium after sub-threshold infrared laser treatment of drusen. Retina. 2011;31(2):235. doi:10.1097/IAE.0b013e3181ec80ad
   PubMed Web of Science ®Google Scholar
• Ivandic BT, Ivandic T. Low-level laser therapy improves vision in patients with age-related macular degeneration. Photomed Laser Surg. 2008;26(3):241–245. doi:10.1089/pho.2007.2132
   PubMed Web of Science ®Google Scholar
• Figueroa M, Schocket LS, DuPont J, Metelitsina TI, Grunwald JE. Effect of laser treatment for dry age related macular degeneration on foveolar choroidal haemodynamics. Br J Ophthalmol. 2004;88(6):792–795. doi:10.1136/bjo.2003.033837
   PubMed Web of Science ®Google Scholar
• Olk RJ, Friberg TR, Stickney KL, et al. Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study. Ophthalmology. 1999;106(11):2082–2090. doi:10.1016/S0161-6420(99)90487-6
   PubMed Web of Science ®Google Scholar
• Virgili G, Michelessi M, Parodi MB, Bacherini D, Evans JR. Laser treatment of drusen to prevent progression to advanced age-related macular degeneration. Cochrane Database Syst Rev. 2015;10.
   Google Scholar
• Guymer RH, Brassington KH, Dimitrov P, et al. Nanosecond‐laser application in intermediate AMD: 12‐month results of fundus appearance and macular function. Clin Experiment Ophthalmol. 2014;42(5):466–479. doi:10.1111/ceo.12247
   Web of Science ®Google Scholar
• Zhang JJ, Sun Y, Hussain AA, Marshall J. Laser-mediated activation of human retinal pigment epithelial cells and concomitant release of matrix metalloproteinases. Invest Ophthalmol Vis Sci. 2012;53(6):2928–2937. doi:10.1167/iovs.11-8585
   Web of Science ®Google Scholar
• Wood JP, Plunkett M, Previn V, Chidlow G, Casson RJ. Nanosecond pulse lasers for retinal applications. Lasers Surg Med. 2011;43(6):499–510. doi:10.1002/lsm.21087
   Web of Science ®Google Scholar
• Guymer RH, Wu Z, Hodgson LA, et al. Subthreshold nanosecond laser intervention in age-related macular degeneration: the LEAD randomized controlled clinical trial. Ophthalmology. 2019;126(6):829–838. doi:10.1016/j.ophtha.2018.09.015
   Web of Science ®Google Scholar
• Jobling AI, Guymer RH, Vessey KA, et al. Nanosecond laser therapy reverses pathologic and molecular changes in age‐related macular degeneration without retinal damage. FASEB J. 2015;29(2):696–710. doi:10.1096/fj.14-262444
   PubMed Web of Science ®Google Scholar
• Spaide RF, Ooto S, Curcio CA. Subretinal drusenoid deposits AKA pseudodrusen. Surv Ophthalmol. 2018;63(6):782–815.
   PubMed Web of Science ®Google Scholar
• Peng Y, Dharssi S, Chen Q, et al. DeepSeeNet: a deep learning model for automated classification of patient-based age-related macular degeneration severity from color fundus photographs. Ophthalmology. 2019;126(4):565–575. doi:10.1016/j.ophtha.2018.11.015
   PubMed Web of Science ®Google Scholar
• Dimitrov PN, Robman LD, Varsamidis M, et al. Relationship between clinical macular changes and retinal function in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2012;53(9):5213–5220. doi:10.1167/iovs.11-8958
   PubMed Web of Science ®Google Scholar
• Gregori NZ, Feuer W, Rosenfeld PJ. Novel method for analyzing snellen visual acuity measurements. Retina. 2010;30(7):1046–1050. doi:10.1097/IAE.0b013e3181d87e04
   PubMed Web of Science ®Google Scholar
• Garrity ST, Sarraf D, Freund KB, Sadda SR. Multimodal imaging of nonneovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2018;59(4):AMD48–64. doi:10.1167/iovs.18-24158
   PubMed Web of Science ®Google Scholar
• Guymer RH, Tao LW, Goh JK, et al. Identification of urinary biomarkers for age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52(7):4639–4644. doi:10.1167/iovs.10-7120
   PubMed Web of Science ®Google Scholar
• Arnold JJ, Heriot W. Age related macular degeneration. BMJ Clin Evid. 2007;2007.
   Google Scholar
• Choroidal Neovascularization Prevention Trial Research Group. Choroidal neovascularization in the choroidal neovascularization prevention trial. Ophthalmology. 1998;105:1364–1372. doi:10.1016/S0161-6420(98)98014-9
   Web of Science ®Google Scholar
• Alamouti B, Funk J. Retinal thickness decreases with age: an OCT study. Br J Ophthalmol. 2003;87(7):899–901. doi:10.1136/bjo.87.7.899
   PubMed Web of Science ®Google Scholar
• Wu Z, Luu CD, Hodgson LA, et al. Secondary and exploratory outcomes of the subthreshold nanosecond laser intervention randomized trial in age-related macular degeneration: a LEAD study report. Ophthalmol Retina. 2019;3(12):1026–1034. doi:10.1016/j.oret.2019.07.008
   Google Scholar
• Vessey KA, Ho T, Jobling AI, et al. Nanosecond laser treatment for age-related macular degeneration does not induce focal vision loss or new vessel growth in the retina. Invest Ophthalmol Vis Sci. 2018;59(2):731–745. doi:10.1167/iovs.17-23098
   PubMed Web of Science ®Google Scholar
• Rosenfeld PJ, Feuer WJ. Warning: do not treat intermediate AMD with laser therapy. Ophthalmology. 2019;126(6):839–840. doi:10.1016/j.ophtha.2018.12.016
   Web of Science ®Google Scholar
• Krishnadev N, Meleth AD, Chew EY. Nutritional supplements for age-related macular degeneration. Curr Opin Ophthalmol. 2010;21(3):184. doi:10.1097/ICU.0b013e32833866ee
   Web of Science ®Google Scholar